Nuveen Nasdaq 100 Dynamic Overwrite Fund 每股年股息为 2.46,收益率为 0.00%。股息每 每季度 支付,最近的除息日为 Jun 15, 2026。
股息收益率
年度股息
除息日
0.00%
$2.46
Jun 15, 2026
支付频率
派息比率
每季度
0.00%
股息历史
除息日
现金金额
股权登记日
付款日期
Jun 15, 2026
$0.738
Jun 15, 2026
Jul 1, 2026
Mar 13, 2026
$0.615
Mar 13, 2026
Apr 1, 2026
Dec 15, 2025
$0.56
Dec 15, 2025
Dec 31, 2025
Sep 15, 2025
$0.56
Sep 15, 2025
Oct 1, 2025
Jun 13, 2025
$0.56
Jun 13, 2025
Jul 1, 2025
Mar 14, 2025
$0.56
Mar 14, 2025
Apr 1, 2025
股息图表
QQQX 股息
QQQX 股息增长率(同比)
Follow-Up Questions
Nuveen Nasdaq 100 Dynamic Overwrite Fund 当前的股息支付和年度股息是多少?
Nuveen Nasdaq 100 Dynamic Overwrite Fund 当前支付的股息为 $0.738。Nuveen Nasdaq 100 Dynamic Overwrite Fund 的年度股息为 $2.46
Nuveen Nasdaq 100 Dynamic Overwrite Fund 的股息支付比率是多少?
Nuveen Nasdaq 100 Dynamic Overwrite Fund 的股息支付比率是 0.00%
QQQX 的除息日是什么?
Nuveen Nasdaq 100 Dynamic Overwrite Fund 的除息日是 Jun 15, 2026。
Nuveen Nasdaq 100 Dynamic Overwrite Fund 多久支付一次股息?
每季度。Nuveen Nasdaq 100 Dynamic Overwrite Fund 上次支付股息是在 Jul 1, 2026
关键数据
前收盘价
$29.87
开盘价
--
当日区间
-
52周范围
-
交易量
--
平均成交量
--
股息收益率
--
每股收益(TTM)
--
市值
--
什么是 QQQX?
Nuveen Nasdaq 100 Dynamic Overwrite Fund is a US-based company operating in industry. The company is headquartered in Chicago, Illinois. The company went IPO on 2014-12-22. Nuveen Nasdaq 100 Dynamic Overwrite Fund (the Fund) is a non-diversified, closed-end management investment company. The Fund’s investment objective is to seek attractive total return with less volatility than the S&P 500 Index. Under normal circumstances, the Fund will invest at least 80% of its assets in a diversified equity portfolio made up of securities comprising the S&P 500 Index (or securities that have economic characteristics that are similar to those securities comprising the S&P 500 Index) that seeks to substantially replicate price movements of the S&P 500 Index and is designed to support the Fund’s option strategy. The company invests in various sectors, including software & services, technology hardware and equipment, semiconductors and semiconductor equipment, financial services, media and entertainment, pharmaceuticals, biotechnology and life sciences, capital goods, health care equipment and services. The Funds’ investment adviser is Nuveen Fund Advisors, LLC.